This paper looks into the impact of a rule change brought about by the 2006 reauthorization of the Ryan White Care Act which resulted in an exogenous shock to federal funding for AIDS Drug Assistance Program (ADAP). ADAP provides people living with HIV (PLWH) with access to life-saving antiretroviral treatments.